InVivoPlus anti-mouse TIGIT

TIGIT limits immune pathology during viral infections. Schorer M et al., 2020 Mar 9, Nat Commun

Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity. Dixon KO et al., 2018 Apr 15, J Immunol

Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Burton BR et al., 2014 Sep 3, Nat Commun

The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Chan CJ et al., 2014 May, Nat Immunol

Agonistic anti-TIGIT treatment inhibits T cell responses in LDLr deficient mice without affecting atherosclerotic lesion development. Foks AC et al., 2013, PLoS One

Cutting edge: TIGIT has T cell-intrinsic inhibitory functions. Joller N et al., 2011 Feb 1, J Immunol